Clinical Trials Browser

OTHER × Lymphoma, Non-Hodgkin × loncastuximab tesirine × Clear all

NCT05053659 2026-02-12

Loncastuximab Tesirine and Venetoclax for Relapsed/ Refractory Non-Hodgkin Lymphoma

Phase 1 Active not recruiting

Lymphoma, Non-Hodgkin